Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-080106
Filing Date
2026-07-02
Accepted
2026-07-02 08:16:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2619264d1_424b5.htm 424B5 524767
2 GRAPHIC tm2619264d1_424b5img001.jpg GRAPHIC 16962
3 GRAPHIC tm2619264d1_424b5sp3img02.jpg GRAPHIC 3733
4 GRAPHIC tm2619264d1_424b5sp3img01.jpg GRAPHIC 5490
  Complete submission text file 0001104659-26-080106.txt   562425
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-293861 | Film No.: 261147815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)